Cardiac conduction diseases: understanding the molecular mechanisms to uncover targets for future treatments

References

• Mesquita T, Zhang R, Cho JH, et al. Mechanisms of sinoatrial node dysfunction in heart failure with preserved ejection fraction. Circulation. 2022;145(1):45–60. doi: 10.1161/CIRCULATIONAHA.121.054976
   PubMed Web of Science ®Google Scholar
• Aránega A, De La Rosa AJ, Franco D. Cardiac conduction system anomalies and sudden cardiac death: insights from murine models. Front physiol. 2012;3:211. doi: 10.3389/fphys.2012.00211
   PubMed Web of Science ®Google Scholar
• Yokokawa T, Ichimura S, Hijioka N, et al. Case reports of a c.475G>T, p.E159* lamin A/C mutation with a family history of conduction disorder, dilated cardiomyopathy and sudden cardiac death. BMC Cardiovasc Disord. 2019;19(1):298. doi: 10.1186/s12872-019-01282-6
   PubMed Web of Science ®Google Scholar
• Keith A, Flack MW. The auriculo-ventricular bundle of the human heart. Annals noninvasive electrocardiol. 2004;9(4):400–409. doi:10.1111/j.1542-474X.2004.94003.x
   PubMed Web of Science ®Google Scholar
• Tawara S. Das Reizleitungssystem Des Säugetierherzens. Eine Anatomisch- Histologische Studie Über das Atrioventrikularbündel und die Purkinjeschen Fäden. Jena: Gustav Fischer; 1906. (English translation–sponsored by Dr. Robert H. Anderson and translated by Dr. Kozo Suma and Dr. Munehiro Shimada. Imperial College press; 2000).
   Google Scholar
• Stephenson RS, Atkinson A, Kottas P, et al. High resolution 3-dimensional imaging of the human cardiac conduction system from microanatomy to mathematical modeling. Sci Rep. 2017;7(1):7188. doi: 10.1038/s41598-017-07694-8
   PubMedGoogle Scholar
• Manoj P, Kim JA, Kim S, et al. Sinus node dysfunction: current understanding and future directions. Am J Physiol Heart Circ Physiol. 2023;324(3):H259–h278. doi: 10.1152/ajpheart.00618.2022
   PubMed Web of Science ®Google Scholar
• Kurian T, Ambrosi C, Hucker W, et al. Anatomy and electrophysiology of the human AV node. Pacing clin electrophysiol. 2010;33(6):754–762. doi: 10.1111/j.1540-8159.2010.02699.x
   PubMed Web of Science ®Google Scholar
• Vigmond EJ, Stuyvers BD. Modeling our understanding of the his-purkinje system. Prog Biophys Mol Biol. 2016;120(1–3):179–188. doi: 10.1016/j.pbiomolbio.2015.12.013
   PubMed Web of Science ®Google Scholar
• Goodyer WR, Beyersdorf BM, Paik DT, et al. Transcriptomic profiling of the developing cardiac conduction system at single-cell resolution circulation research. Circ Res. 2019;125(4):379–397. doi: 10.1161/CIRCRESAHA.118.314578
   PubMed Web of Science ®Google Scholar
• Goodyer WR, Beyersdorf BM, Duan L, et al. In vivo visualization and molecular targeting of the cardiac conduction system. J Clin Investig. 2022;132(20). doi: 10.1172/JCI156955
   PubMed Web of Science ®Google Scholar
• Yaniv Y, Lakatta EG, Maltsev VA. From two competing oscillators to one coupled-clock pacemaker cell system. Front Physiol. 2015;6:28. doi: 10.3389/fphys.2015.00028
   PubMed Web of Science ®Google Scholar
• Maltsev VA, Lakatta EG. Dynamic interactions of an intracellular Ca2+ clock and membrane ion channel clock underlie robust initiation and regulation of cardiac pacemaker function. Cardiovasc Res. 2008;77(2):274–284. doi: 10.1093/cvr/cvm058
   PubMed Web of Science ®Google Scholar
• Bychkov R, Juhaszova M, Tsutsui K, et al. Synchronized cardiac impulses emerge from heterogeneous local calcium signals within and among cells of pacemaker tissue. JACC Clin Electrophysiol. 2020;6(8):907–931. doi: 10.1016/j.jacep.2020.06.022
   PubMedGoogle Scholar
• Maltsev AV, Stern MD, Lakatta EG, et al. A novel conceptual model of heart rate autonomic modulation based on a small-world modular structure of the sinoatrial node. Front Physiol. 2023;14:1276023. doi: 10.3389/fphys.2023.1276023
   PubMed Web of Science ®Google Scholar
• Fenske S, Hennis K, Rotzer RD, et al. cAMP-dependent regulation of HCN4 controls the tonic entrainment process in sinoatrial node pacemaker cells. Nat Commun. 2020;11(1):5555. doi: 10.1038/s41467-020-19304-9
   PubMed Web of Science ®Google Scholar
• Hanna P, LA J, ShivkumarKalyanam K. Cardiac neuroanatomy for the cardiac electrophysiologist. J Atr Fibrillation. 2020;13(1):2407. doi: 10.4022/jafib.2407
   PubMedGoogle Scholar
• Hou Y, Scherlag BJ, Lin J, et al. Ganglionated plexi modulate extrinsic cardiac autonomic nerve input: effects on sinus rate, atrioventricular conduction, refractoriness, and inducibility of atrial fibrillation. J Am Coll Cardiol. 2007;50(1):61–68. doi: 10.1016/j.jacc.2007.02.066
   PubMed Web of Science ®Google Scholar
• Shen MJ, Zipes DP. Role of the autonomic nervous system in modulating cardiac arrhythmias. Circ Res. 2014;114(6):1004–1021. doi: 10.1161/CIRCRESAHA.113.302549
   PubMed Web of Science ®Google Scholar
• Hennis K, Biel M, Wahl-Schott C, et al. Beyond pacemaking: HCN channels in sinoatrial node function. Prog Biophys Mol Biol. 2021;166:51–60. doi: 10.1016/j.pbiomolbio.2021.03.004
   PubMed Web of Science ®Google Scholar
• Jensen PN, Gronroos NN, Chen LY, et al. Incidence of and risk factors for sick sinus syndrome in the general population. J Am Coll Cardiol. 2014;64(6):531–538. doi: 10.1016/j.jacc.2014.03.056
   PubMed Web of Science ®Google Scholar
• Ahmed A, Pothineni Naga Venkata K, Charate R, et al. Inappropriate sinus tachycardia: etiology, pathophysiology, and management. J Am Coll Cardiol. 2022;79(24):2450–2462. doi: 10.1016/j.jacc.2022.04.019
   PubMed Web of Science ®Google Scholar
• van Eif VWW, Stefanovic S, van Duijvenboden K, et al. Transcriptome analysis of mouse and human sinoatrial node cells reveals a conserved genetic program. Development. 2019;146(8). doi: 10.1242/dev.173161
   PubMed Web of Science ®Google Scholar
• Torrente AG, Zhang R, Wang H, et al. Contribution of small conductance K(+) channels to sinoatrial node pacemaker activity: insights from atrial-specific Na(+)/Ca(2+) exchange knockout mice. J Physiol. 2017;595(12):3847–3865. doi: 10.1113/JP274249
   PubMed Web of Science ®Google Scholar
• Lai MH, Wu Y, Gao Z, et al. BK channels regulate sinoatrial node firing rate and cardiac pacing in vivo. Am J Physiol Heart Circ Physiol. 2014;307(9):H1327–38. doi: 10.1152/ajpheart.00354.2014
   PubMed Web of Science ®Google Scholar
• Pineda S, Nikolova-Krstevski V, Leimena C, et al. Conserved role of the large conductance calcium-activated potassium channeL, K(Ca)1.1, in sinus node function and arrhythmia risk. Circ Genom Precis Med. 2021;14(2):e003144. doi: 10.1161/CIRCGEN.120.003144
   PubMed Web of Science ®Google Scholar
• Petkova M, Atkinson AJ, Yanni J, et al. Identification of key small non-coding MicroRNAs controlling pacemaker mechanisms in the human sinus node. J Am Heart Assoc. 2020;9(20):e016590. doi: 10.1161/JAHA.120.016590
   PubMed Web of Science ®Google Scholar
• Li N, Artiga E, Kalyanasundaram A, et al. Altered microRNA and mRNA profiles during heart failure in the human sinoatrial node. Sci Rep. 2021;11(1):19328. doi: 10.1038/s41598-021-98580-x
   PubMed Web of Science ®Google Scholar
• D’Souza A, Pearman CM, Wang Y, et al. Targeting miR-423-5p reverses exercise training–induced HCN4 channel remodeling and sinus bradycardia. Circ Res. 2017;121(9):1058–1068. doi: 10.1161/CIRCRESAHA.117.311607
   PubMed Web of Science ®Google Scholar
• Zhang J, Wei F, Ding L, et al. MicroRNA-1976 regulates degeneration of the sinoatrial node by targeting Ca(v)1.2 and Ca(v)1.3 ion channels. J Mol Cell Cardiol. 2019;134:74–85. doi: 10.1016/j.yjmcc.2019.06.018
   PubMed Web of Science ®Google Scholar
• Yang B, Huang Y, Zhang H, et al. Mitochondrial thioredoxin-2 maintains HCN4 expression and prevents oxidative stress-mediated sick sinus syndrome. J Mol Cell Cardiol. 2020;138:291–303. doi: 10.1016/j.yjmcc.2019.10.009
   PubMed Web of Science ®Google Scholar
• Pereira CH, Bare DJ, Rosas PC, et al. The role of P21-activated kinase (Pak1) in sinus node function. J Mol Cell Cardiol. 2023;179:90–101. doi: 10.1016/j.yjmcc.2023.04.004
   PubMed Web of Science ®Google Scholar
• van Ouwerkerk AF, Hall AW, Kadow ZA, et al. Epigenetic and transcriptional networks underlying atrial fibrillation. Circ Res. 2020;127(1):34–50. doi: 10.1161/CIRCRESAHA.120.316574
   PubMed Web of Science ®Google Scholar
• Egom EE, Vella K, Hua R, et al. Impaired sinoatrial node function and increased susceptibility to atrial fibrillation in mice lacking natriuretic peptide receptor C. J Physiol. 2015;593(5):1127–1146. doi: 10.1113/jphysiol.2014.283135
   PubMed Web of Science ®Google Scholar
• Lazzerini PE, Capecchi PL, Laghi-Pasini F, et al. Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias. Nat Rev Cardiol. 2017;14(9):521–535. doi: 10.1038/nrcardio.2017.61
   PubMed Web of Science ®Google Scholar
• Brucato A, Cimaz R, Catelli L, et al. Anti-Ro–Associated sinus bradycardia in newborns. Circulation. 2000;102(11):e88–e89. doi: 10.1161/01.CIR.102.11.e88
   PubMed Web of Science ®Google Scholar
• Qu Y, Baroudi G, Yue Y, et al. Novel molecular mechanism involving α1D (Cav1.3) L-Type calcium channel in autoimmune-associated sinus bradycardia. Circulation. 2005;111(23):3034–3041. doi: 10.1161/CIRCULATIONAHA.104.517326
   PubMed Web of Science ®Google Scholar
• Lazzerini PE, Murthy Ginjupalli VK, Srivastava U, et al. Anti-Ro/SSA Antibodies Blocking Calcium Channels as a potentially reversible cause of atrioventricular block in adults. JACC Clin Electrophysiol. 2023;9(8):1631–1648. doi: 10.1016/j.jacep.2023.03.007
   PubMedGoogle Scholar
• Chiale PA, Ferrari I, Mahler E, et al. Differential profile and biochemical effects of antiautonomic membrane receptor antibodies in ventricular arrhythmias and sinus node dysfunction. Circulation. 2001;103(13):1765–1771. doi: 10.1161/01.CIR.103.13.1765
   PubMed Web of Science ®Google Scholar
• Lee HC, Huang KT, Wang XL, et al. Autoantibodies and cardiac arrhythmias. Heart Rhythm. 2011;8(11):1788–1795. doi: 10.1016/j.hrthm.2011.06.032
   PubMed Web of Science ®Google Scholar
• Glukhov AV, Hage LT, Hansen BJ, et al. Sinoatrial node reentry in a canine chronic left ventricular infarct model: role of intranodal fibrosis and heterogeneity of refractoriness. Circ Arrhythm Electrophysiol. 2013;6(5):984–994. doi: 10.1161/CIRCEP.113.000404
   PubMed Web of Science ®Google Scholar
• Fedorowski A, Fanciulli A, Raj SR, et al. Cardiovascular autonomic dysfunction in post-COVID-19 syndrome: a major health-care burden. Nat Rev Cardiol. 2024. doi: 10.1038/s41569-023-00962-3
   Web of Science ®Google Scholar
• Aranyó J, Bazan V, Lladós G, et al. Inappropriate sinus tachycardia in post-COVID-19 syndrome. Sci Rep. 2022;12(1):298. doi: 10.1038/s41598-021-03831-6
   PubMed Web of Science ®Google Scholar
• de Asmundis C, Pannone L, Lakkireddy D, et al. Targeted treatment of inappropriate sinoatrial node tachycardia based on electrophysiological and structural mechanisms. Am J Cardiol. 2022;183:24–32. doi: 10.1016/j.amjcard.2022.07.041
   PubMed Web of Science ®Google Scholar
• Kusumoto FM, Schoenfeld MH, Barrett C, et al. 2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the Heart rhythm society. Circulation. 2019;140(8):e382–e482. doi: 10.1161/CIR.0000000000000628
   PubMed Web of Science ®Google Scholar
• Alboni P, Ratto B, Cappato R, et al. Clinical effects of oral theophylline in sick sinus syndrome. Am Heart J. 1991;122(5):1361–1367. doi: 10.1016/0002-8703(91)90578-6
   PubMed Web of Science ®Google Scholar
• MacDonald EA, Rose RA, Quinn TA. Neurohumoral control of sinoatrial node activity and heart rate: insight from experimental models and findings from humans frontiers in physiology. Front Physiol. 2020;11:170. doi: 10.3389/fphys.2020.00170
   PubMed Web of Science ®Google Scholar
• Sonoura T, Kodera S, Shakya S, et al. Efficacy of cilostazol for sick sinus syndrome to avoid permanent pacemaker implantation: a retrospective case-control study. J Cardiol. 2019;74(4):328–332. doi: 10.1016/j.jjcc.2019.03.007
   PubMed Web of Science ®Google Scholar
• Choudhury M, Boyett MR, Morris GM. Biology of the Sinus Node and its disease arrhythm. Electrophysiol Rev. 2015;4(1):28–34. doi: 10.15420/aer.2015.4.1.28
   PubMed Web of Science ®Google Scholar
• Cappato R, Castelvecchio S, Ricci C, et al. Clinical efficacy of Ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo-controlled, Double-Blind Crossover Evaluation. J Am Colle Cardiol. 2012;60(15):1323–1329. doi: 10.1016/j.jacc.2012.06.031
   PubMed Web of Science ®Google Scholar
• Ptaszynski P, Kaczmarek K, Ruta J, et al. Metoprolol succinate vs. ivabradine in the treatment of inappropriate sinus tachycardia in patients unresponsive to previous pharmacological therapy. EP Europace. 2012;15(1):116–121. doi: 10.1093/europace/eus204
   PubMed Web of Science ®Google Scholar
• Robinson RB, Brink PR, Cohen IS, et al. If and the biological pacemaker. Pharmacol Res. 2006;53(5):407–415. doi: 10.1016/j.phrs.2006.03.007
   PubMed Web of Science ®Google Scholar
• Cingolani E, Goldhaber JI, Marbán E. Next-generation pacemakers: from small devices to biological pacemakers. Nat Rev Cardiol. 2018;15(3):139–150. doi: 10.1038/nrcardio.2017.165
   PubMed Web of Science ®Google Scholar
• Clark BA, Prystowsky EN. Electrocardiography of atrioventricular block. Cardiol Clin. 2023;41(3):307–313. doi: 10.1016/j.ccl.2023.03.007
   PubMed Web of Science ®Google Scholar
• Katritsis DG, Camm AJ. Atrioventricular nodal reentrant tachycardia. Circulation. 2010;122(8):831–840. doi: 10.1161/CIRCULATIONAHA.110.936591
   PubMed Web of Science ®Google Scholar
• Rudbeck-Resdal J, Christiansen MK, Johansen JB, et al. Aetiologies and temporal trends of atrioventricular block in young patients: a 20-year nationwide study europace: European pacing, arrhythmias, and cardiac electrophysiology: journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. Europace. 2019;21(11):1710–1716. doi: 10.1093/europace/euz206
   PubMed Web of Science ®Google Scholar
• Asatryan B, Medeiros-Domingo A. Molecular and genetic insights into progressive cardiac conduction disease europace: European pacing, arrhythmias, and cardiac electrophysiology: journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. Europace. 2019;21(8):1145–1158. doi: 10.1093/europace/euz109
   PubMedGoogle Scholar
• Rivaud MR, Marchal GA, Wolswinkel R, et al. Functional modulation of atrio-ventricular conduction by enhanced late sodium current and calcium-dependent mechanisms in Scn5a1798insD/+ mice. Europace. 2020;22(10):1579–1589. doi: 10.1093/europace/euaa127
   PubMed Web of Science ®Google Scholar
• Splawski I, Timothy KW, Sharpe LM, et al. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell. 2004;119(1):19–31. doi: 10.1016/j.cell.2004.09.011
   PubMed Web of Science ®Google Scholar
• Ye D, Tester DJ, Zhou W, et al. A pore-localizing CACNA1C-E1115K missense mutation, identified in a patient with idiopathic QT prolongation, bradycardia, and autism spectrum disorder, converts the L-type calcium channel into a hybrid nonselective monovalent cation channel. Heart Rhythm. 2019;16(2):270–278. doi: 10.1016/j.hrthm.2018.08.030
   PubMed Web of Science ®Google Scholar
• Mangoni ME, Traboulsie A, Leoni AL, et al. Bradycardia and slowing of the atrioventricular conduction in mice lacking CaV3.1/alpha1G T-type calcium channels. Circ Res. 2006;98(11):1422–1430. doi: 10.1161/01.RES.0000225862.14314.49
   PubMed Web of Science ®Google Scholar
• Suetterlin K, Männikkö R, Flossmann E, et al. Andersen-tawil syndrome presenting with complete heart block. J Neuromuscul Dis. 2021;8(1):151–154. doi: 10.3233/JND-200572
   PubMedGoogle Scholar
• Zhou J, Ding WG, Makiyama T, et al. A novel HCN4 mutation, G1097W, is associated with atrioventricular block. Circ J. 2014;78(4):938–942. doi: 10.1253/circj.CJ-13-0996
   PubMed Web of Science ®Google Scholar
• Song MY, Yuan JX. Introduction to TRP channels: structure, function, and regulation. Adv Exp Med Biol. 2010;661:99–108.
   PubMed Web of Science ®Google Scholar
• Bianchi B, Ozhathil LC, Medeiros-Domingo A, et al. Four TRPM4 cation channel mutations found in cardiac conduction diseases lead to altered protein stability. Front Physiol. 2018;9:177. doi: 10.3389/fphys.2018.00177
   PubMed Web of Science ®Google Scholar
• Kruse M, Schulze-Bahr E, Corfield V, et al. Impaired endocytosis of the ion channel TRPM4 is associated with human progressive familial heart block type I. J Clin Investig. 2009;119(9):2737–2744. doi: 10.1172/JCI38292
   PubMed Web of Science ®Google Scholar
• Kim D, Shinohara T, Joung B, et al. Calcium dynamics and the mechanisms of atrioventricular junctional rhythm. J Am Coll Cardiol. 2010;56(10):805–812. doi: 10.1016/j.jacc.2010.03.070
   PubMed Web of Science ®Google Scholar
• Cheng H, Smith GL, Hancox JC, et al. Inhibition of spontaneous activity of rabbit atrioventricular node cells by KB-R7943 and inhibitors of sarcoplasmic reticulum Ca(2+ATPase). Cell Calcium. 2011;49(1):56–65. doi: 10.1016/j.ceca.2010.11.008
   PubMed Web of Science ®Google Scholar
• Hata Y, Ichimata S, Hirono K, et al. Pathological and comprehensive genetic investigation of autopsy cases of idiopathic bradyarrhythmia. Circ J. 2022;87(1):111–119. doi: 10.1253/circj.CJ-22-0397
   PubMed Web of Science ®Google Scholar
• Pipilas DC, Johnson CN, Webster G, et al. Novel calmodulin mutations associated with congenital long QT syndrome affect calcium current in human cardiomyocytes heart. Heart Rhythm. 2016;13(10):2012–2019. doi: 10.1016/j.hrthm.2016.06.038
   PubMed Web of Science ®Google Scholar
• Musa H, Murphy NP, Curran J, et al. Common human ANK2 variant confers in vivo arrhythmia phenotypes. Heart Rhythm. 2016;13(9):1932–1940. doi: 10.1016/j.hrthm.2016.06.012
   PubMed Web of Science ®Google Scholar
• Temple IP, Inada S, Dobrzynski H, et al. Connexins and the atrioventricular node heart. Heart Rhythm. 2013;10(2):297–304. doi: 10.1016/j.hrthm.2012.10.020
   PubMed Web of Science ®Google Scholar
• Tan NY, Witt CM, Oh JK, et al. Left bundle branch block current and future perspectives. Circ Arrhythm Electrophysiol. 2020;13(4):e008239. doi: 10.1161/CIRCEP.119.008239
   PubMed Web of Science ®Google Scholar
• Delmar M, Makita N. Cardiac connexins, mutations and arrhythmias. Curr Opin Cardiol. 2012;27(3):236–241. doi: 10.1097/HCO.0b013e328352220e
   PubMed Web of Science ®Google Scholar
• Seki A, Ishikawa T, Daumy X, et al. Progressive atrial conduction defects associated with bone malformation caused by a connexin-45 mutation. J Am Coll Cardiol. 2017;70(3):358–370. doi: 10.1016/j.jacc.2017.05.039
   PubMed Web of Science ®Google Scholar
• Zhang J, Vincent KP, Peter AK, et al. Cardiomyocyte expression of ZO-1 is essential for normal atrioventricular conduction but does not alter ventricular function. Circ Res. 2020;127(2):284–297. doi: 10.1161/CIRCRESAHA.119.315539
   PubMed Web of Science ®Google Scholar
• Liang Y, Sheikh F. Zippering up a role for ZO-1 in atrioventricular node conduction and disease. Circ Res. 2020;127(2):298–300. doi: 10.1161/CIRCRESAHA.120.317291
   PubMed Web of Science ®Google Scholar
• Kreuzberg MM, Schrickel JW, Ghanem A, et al. Connexin30.2 containing gap junction channels decelerate impulse propagation through the atrioventricular node. Proceedings of the National Academy of Sciences of the United States of America. 2006;103(15):5959–5964.
   Google Scholar
• Hucker WJ, McCain ML, Laughner JI, et al. Connexin 43 expression delineates two discrete pathways in the human atrioventricular junction. Anatomical Record (Hoboken, NJ: 2007). 2008;291(2):204–215. doi: 10.1002/ar.20631
   PubMedGoogle Scholar
• Nikolski VP, Jones SA, Lancaster MK, et al. Cx43 and dual-pathway electrophysiology of the atrioventricular node and atrioventricular nodal reentry. Circ Res. 2003;92(4):469–475. doi: 10.1161/01.RES.0000059304.97120.2F
   PubMed Web of Science ®Google Scholar
• Hulsmans M, Clauss S, Xiao L, et al. Macrophages Facilitate Electrical Conduction in the heart. Cell. 2017;169(3):510–522.e20. doi: 10.1016/j.cell.2017.03.050
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S, Munshi NV. Development of the cardiac conduction system cold Spring harbor perspectives in biology. Cold Spring Harbor Perspect Biol. 2020;12(12):a037408. doi: 10.1101/cshperspect.a037408
   PubMed Web of Science ®Google Scholar
• Pashmforoush M, Lu JT, Chen H, et al. Nkx2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block. Cell. 2004;117(3):373–386. doi: 10.1016/s0092-8674(04)00405-2
   PubMed Web of Science ®Google Scholar
• van Ouwerkerk AF, Bosada FM, van Duijvenboden K, et al. Patient-specific TBX5-G125R variant induces profound transcriptional deregulation and atrial dysfunction. circulation. 2022;145(8):606–619. doi: 10.1161/CIRCULATIONAHA.121.054347
   PubMed Web of Science ®Google Scholar
• Captur G, Arbustini E, Bonne G, et al. Lamin and the heart. Heart. 2018;104(6):468–479. doi: 10.1136/heartjnl-2017-312338
   PubMed Web of Science ®Google Scholar
• Berk JM, Tifft KE, Wilson KL. The nuclear envelope LEM-domain protein emerin. nucleus (Austin Tex). 2013;4(4):298–314. doi: 10.4161/nucl.25751
   PubMed Web of Science ®Google Scholar
• Jakobs PM, Hanson EL, Crispell KA, et al. Novel lamin A/C mutations in two families with dilated cardiomyopathy and conduction system disease. J Card Fail. 2001;7(3):249–256. doi: 10.1054/jcaf.2001.26339
   PubMed Web of Science ®Google Scholar
• Kong D, Zhan Y, Liu C, et al. a novel mutation of the EMD gene in a family with cardiac conduction abnormalities and a high incidence of sudden cardiac death. Pharmacogenomics personalized med[Cdata[pharmacogenomics and personalized Medicine]]. 2019;12:319–327. doi: 10.2147/PGPM.S221444
   PubMed Web of Science ®Google Scholar
• Lazzerini PE, Abbate A, Boutjdir M, et al. Fir(e)ing the rhythm: inflammatory cytokines and cardiac arrhythmias. JACC basic transl sci. 2023;8(6):728–750. doi: 10.1016/j.jacbts.2022.12.004
   PubMedGoogle Scholar
• Lazzerini PE, Acampa M, Cupelli M, et al. Unravelling atrioventricular block risk in inflammatory diseases: systemic inflammation acutely delays atrioventricular conduction via a cytokine-mediated inhibition of Connexin43 expression. J Am Heart Assoc. 2021;10(21):e022095. doi: 10.1161/JAHA.121.022095
   PubMed Web of Science ®Google Scholar
• Zhu X, Wang Y, Xiao Y, et al. Arrhythmogenic mechanisms of interleukin-6 combination with hydroxychloroquine and azithromycin in inflammatory diseases. Sci Rep. 2022;12(1):1075. doi: 10.1038/s41598-022-04852-5
   PubMed Web of Science ®Google Scholar
• Verweij N, Mateo Leach I, van den Boogaard M, et al. Genetic determinants of P wave duration and PR segment. Circ Cardiovasc Genet. 2014;7(4):475–481. doi: 10.1161/CIRCGENETICS.113.000373
   PubMedGoogle Scholar
• Guan H, Liu J, Ding J, et al. Arrhythmias in patients with coronavirus disease 2019 (COVID-19) in Wuhan, China: incidences and implications. J Electrocardiol. 2021;65:96–101. doi: 10.1016/j.jelectrocard.2021.01.012
   PubMed Web of Science ®Google Scholar
• Lazzerini PE, Laghi-Pasini F, Boutjdir M, et al. Inflammatory cytokines and cardiac arrhythmias: the lesson from COVID-19 nature reviews immunology. Nat Rev Immunol. 2022;22(5):270–272. doi: 10.1038/s41577-022-00714-3
   PubMed Web of Science ®Google Scholar
• Lazzerini PE, Capecchi PL, Laghi-Pasini F, et al. Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias. Nat Rev Cardiol. 2017;14(9):521–535. doi: 10.1038/nrcardio.2017.61
   PubMed Web of Science ®Google Scholar
• Wainwright B, Bhan R, Trad C, et al. Autoimmune-mediated congenital heart block. Best Pract Res Clin Obstet Gynaecol. 2020;64:41–51. doi: 10.1016/j.bpobgyn.2019.09.001
   PubMed Web of Science ®Google Scholar
• Akuka A, Ben-Shabat N, Watad A, et al. Association of anti-Ro seropositivity with cardiac rhythm and conduction disturbances. Eur Heart J. 2022;43(47):4912–4919. doi: 10.1093/eurheartj/ehac516
   PubMed Web of Science ®Google Scholar
• Korkmaz S, Zitron E, Bangert A, et al. Provocation of an autoimmune response to cardiac voltage-gated sodium channel NaV1.5 induces cardiac conduction defects in rats. J Am Coll Cardiol. 2013;62(4):340–349. doi: 10.1016/j.jacc.2013.04.041
   PubMed Web of Science ®Google Scholar
• Mesirca P, Nakao S, Nissen SD, et al. Intrinsic electrical remodeling underlies atrioventricular block in athletes. Circ Res. 2021;129(1):e1–e20. doi: 10.1161/CIRCRESAHA.119.316386
   PubMed Web of Science ®Google Scholar
• Willis R, Seif AM, McGwin G Jr., et al. Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort. Lupus. 2012;21(8):830–835. doi: 10.1177/0961203312437270
   PubMed Web of Science ®Google Scholar
• Izmirly P, Kim M, Friedman DM, et al. Hydroxychloroquine to prevent recurrent congenital heart block in fetuses of anti-SSA/Ro-positive mothers. J Am Coll Cardiol. 2020;76(3):292–302. doi: 10.1016/j.jacc.2020.05.045
   PubMed Web of Science ®Google Scholar
• Lazzerini PE, Salvini V, Srivastava U, et al. Anti-Ca(v)1.2 Antibody-Induced Atrioventricular Block as a novel form in the adult: long-term pacemaker-sparing activity of Hydroxychloroquine. Circ Arrhythm Electrophysiol. 2022;15(7):e011042. doi: 10.1161/CIRCEP.122.011042
   PubMed Web of Science ®Google Scholar
• Lazzerini PE, Capecchi PL, Laghi-Pasini F. Isolated atrioventricular block of unknown origin in adults and anti-Ro/SSA antibodies: clinical evidence, putative mechanisms and therapeutic implications. Heart Rhythm. 2015;12(2):449–454. doi: 10.1016/j.hrthm.2014.10.031
   PubMed Web of Science ®Google Scholar
• Santos-Pardo I, Martínez-Morillo M, Villuendas R, et al. Anti-ro antibodies and reversible atrioventricular block the new. Engl J Med. 2013;368(24):2335–2337. doi: 10.1056/NEJMc1300484
   PubMed Web of Science ®Google Scholar
• Egom EE, Kruzliak P, Rotrekl V, et al. The effect of the sphingosine-1-phosphate analogue FTY720 on atrioventricular nodal tissue. J Cell Mol Med. 2015;19(7):1729–1734. doi: 10.1111/jcmm.12549
   PubMed Web of Science ®Google Scholar
• Sanna MG, Vincent KP, Repetto E, et al. Bitopic sphingosine 1-phosphate receptor 3 (S1P3) antagonist rescue from complete heart block: pharmacological and genetic evidence for direct S1P3 regulation of mouse cardiac conduction. Mol Pharmacol. 2016;89(1):176–186. doi: 10.1124/mol.115.100222
   PubMed Web of Science ®Google Scholar
• Knops RE, Reddy VY, Ip JE, et al. A dual-chamber leadless pacemaker the new. Engl J Med. 2023;388(25):2360–2370. doi: 10.1056/NEJMoa2300080
   PubMed Web of Science ®Google Scholar
• Aksu T, Gopinathannair R, Bozyel S, et al. Cardioneuroablation for treatment of atrioventricular block. Circ Arrhythm Electrophysiol. 2021;14(9):e010018. doi: 10.1161/CIRCEP.121.010018
   PubMed Web of Science ®Google Scholar
• Rivarola EWR, Hachul D, Wu TC, et al. Long-term outcome of cardiac denervation procedures: the anatomically guided septal approach. JACC Clin Electrophysiol. 2023;9(8):1344–1353. doi: 10.1016/j.jacep.2023.01.032
   PubMedGoogle Scholar
• Maass K, Shekhar A, Lu J, et al. Isolation and characterization of embryonic stem cell-derived cardiac purkinje cells. Stem Cells. 2015;33(4):1102–1112. doi: 10.1002/stem.1921
   PubMed Web of Science ®Google Scholar
• Logantha S, Cai XJ, Yanni J, et al. Remodeling of the Purkinje Network in congestive heart failure in the rabbit. Circ Heart Fail. 2021;14(7):e007505. doi: 10.1161/CIRCHEARTFAILURE.120.007505
   PubMed Web of Science ®Google Scholar
• He BJ, Boyden P, Scheinman M. Ventricular arrhythmias involving the His-Purkinje system in the structurally abnormal heart. Pacing Clin Electrophysiol. 2018;41(9):1051–1059. doi: 10.1111/pace.13465
   PubMed Web of Science ®Google Scholar
• Watanabe H, Koopmann TT, Le Scouarnec S, et al. Sodium channel β1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J Clin Investig. 2008;118(6):2260–2268. doi: 10.1172/JCI33891
   PubMed Web of Science ®Google Scholar
• Poelzing S, Rosenbaum DS. Altered connexin43 expression produces arrhythmia substrate in heart failure. Am J Physiol Heart Circ Physiol. 2004;287(4):H1762–70. doi:10.1152/ajpheart.00346.2004
   PubMed Web of Science ®Google Scholar
• Simon AM, Goodenough DA, Paul DL. Mice lacking connexin40 have cardiac conduction abnormalities characteristic of atrioventricular block and bundle branch block. Curr Biol. 1998;8(5):295–298. doi:10.1016/S0960-9822(98)70113-7
   PubMed Web of Science ®Google Scholar
• Ladenvall P, Andersson B, Dellborg M, et al. Genetic variation at the human connexin 43 locus but not at the connexin 40 locus is associated with left bundle branch block. Open Heart. 2015;2(1):e000187. doi: 10.1136/openhrt-2014-000187
   PubMedGoogle Scholar
• Maguy A, Le Bouter S, Comtois P, et al. Ion channel subunit expression changes in cardiac purkinje fibers: a potential role in conduction abnormalities associated with congestive heart failure circulation research. Circ Res. 2009;104(9):1113–1122. doi: 10.1161/CIRCRESAHA.108.191809
   PubMed Web of Science ®Google Scholar
• Peng ML, Fu Y, Zhang Y, et al. Recovery of complete left bundle branch block in a dilated cardiomyopathy patient after treatment with sacubitril/valsartan: a case report. Medicine (Baltimore). 2022;101(27):e29330. doi: 10.1097/MD.0000000000029330
   PubMed Web of Science ®Google Scholar
• Abudan A, Parimi N, Sami F, et al. Abstract 16271: resolution of left bundle branch block with Sacubitril/Valsartan in patients with heart failure with reduced ejection fraction. Circulation. 2020;142(Suppl_3):A16271–A16271. doi: 10.1161/circ.142.suppl_3.16271
   Google Scholar
• Chung MK, Patton KK, Lau C-P, et al. 2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure. Heart Rhythm. 2023;20(9):e17–e91. doi: 10.1016/j.hrthm.2023.03.1538
   PubMed Web of Science ®Google Scholar
• Arnold AD, Shun-Shin MJ, Ali N, et al. Contributions of atrioventricular delay shortening and ventricular resynchronization to hemodynamic benefits of biventricular pacing. JACC Clin Electrophysiol. 2023;9(1):117–119. doi: 10.1016/j.jacep.2022.07.024
   PubMedGoogle Scholar
• Jones S, Lumens J, Sohaib SMA, et al. Cardiac resynchronization therapy: mechanisms of action and scope for further improvement in cardiac function europace: European pacing, arrhythmias, and cardiac electrophysiology: journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. Europace. 2017;19(7):1178–1186. doi: 10.1093/europace/euw136
   PubMedGoogle Scholar
• Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure the new. Engl J Med. 2002;346(24):1845–1853. doi: 10.1056/NEJMoa013168
   PubMed Web of Science ®Google Scholar
• Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure the new. Engl J Med. 2004;350(21):2140–2150. doi: 10.1056/NEJMoa032423
   PubMed Web of Science ®Google Scholar
• Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure the new. N Engl J Med. 2005;352(15):1539–1549. doi: 10.1056/NEJMoa050496
   PubMed Web of Science ®Google Scholar
• Higgins SL, Hummel JD, Niazi IK, et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol. 2003;42(8):1454–1459. doi: 10.1016/S0735-1097(03)01042-8
   PubMed Web of Science ®Google Scholar
• Kindermann M, Hennen B, Jung J, et al. Biventricular versus conventional right ventricular stimulation for patients with standard pacing indication and left ventricular dysfunction: the homburg biventricular pacing evaluation (HOBIPACE). J Am Coll Cardiol. 2006;47(10):1927–1937. doi: 10.1016/j.jacc.2005.12.056
   PubMed Web of Science ®Google Scholar
• Leclercq C, Walker S, Linde C, et al. Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J. 2002;23(22):1780–1787. doi: 10.1053/euhj.2002.3232
   PubMed Web of Science ®Google Scholar
• Young JB, Abraham WT, Smith AL, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD trial. Jama. 2003;289(20):2685–2694. doi: 10.1001/jama.289.20.2685
   PubMed Web of Science ®Google Scholar
• Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay the new. Engl J Med. 2001;344(12):873–880. doi: 10.1056/NEJM200103223441202
   PubMed Web of Science ®Google Scholar
• Huang W, Su L, Wu S, et al. Long-term outcomes of his bundle pacing in patients with heart failure with left bundle branch block. Heart. 2019;105(2):137–143. doi: 10.1136/heartjnl-2018-313415
   PubMed Web of Science ®Google Scholar
• Arnold AD, Shun-Shin MJ, Keene D, et al. His resynchronization versus biventricular pacing in patients with heart failure and left bundle branch block. J Am Coll Cardiol. 2018;72(24):3112–3122. doi: 10.1016/j.jacc.2018.09.073
   PubMed Web of Science ®Google Scholar
• Upadhyay GA, Vijayaraman P, Nayak HM, et al. On-treatment comparison between corrective his bundle pacing and biventricular pacing for cardiac resynchronization: a secondary analysis of the his-SYNC Pilot trial. Heart Rhythm. 2019;16(12):1797–1807. doi: 10.1016/j.hrthm.2019.05.009
   PubMed Web of Science ®Google Scholar
• Padala SK, Ellenbogen KA. Left bundle branch pacing is the best approach to physiological pacing. Heart Rhythm O2. 2020;1(1):59–67. doi: 10.1016/j.hroo.2020.03.002
   PubMedGoogle Scholar
• Kim JA, Kim SE, Ellenbogen KA, et al. Clinical outcomes of conduction system pacing versus biventricular pacing for cardiac resynchronization therapy: a systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2023;34(8):1718–1729. doi: 10.1111/jce.15976
   PubMed Web of Science ®Google Scholar